Lilly Last Hope for Alzheimer’s as Pfizer, J&J Bow Out

For millions of people suffering from Alzheimer’s disease, an experimental drug from Eli Lilly & Co. may now be their last hope for treatment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.